Bio Path Holdings Inc (BPTH.OQ)
1.87USD
20 Apr 2018
$-0.03 (-1.58%)
$1.90
$1.91
$1.91
$1.73
41,879
46,990
$7.30
$1.53
Latest Key Developments (Source: Significant Developments)
Bio-Path Holdings Reports Full Year 2017 Financial Results
April 3 (Reuters) - Bio Path Holdings Inc
Bio-Path Holdings Announces Interim Data From Phase 2 Clinical Trial Of Prexigebersen
April 3 (Reuters) - Bio Path Holdings Inc
Bio-Path Holdings Announces 1-For-10 Reverse Stock Split
Feb 9 (Reuters) - Bio Path Holdings Inc
Bio-Path Holdings Q3 loss per share $0.02
Nov 9 (Reuters) - Bio Path Holdings Inc
Bio-Path Holdings announces $4 mln registered direct offering
Nov 3 (Reuters) - Bio Path Holdings Inc
Bio Path Holdings says plans to add a new CFO with significant financial experience
June 20 (Reuters) - Bio Path Holdings Inc
Bio Path Holdings reports Q1 loss per share of $0.01
May 11 (Reuters) - Bio Path Holdings Inc
Bio-Path reported Q2 EPS ($0.02)
Bio Path Holdings Inc
Bio Path Holdings announces $10 million registered direct offering
Bio Path Holdings Inc
BRIEF-Bio-Path Holdings Reports Full Year 2017 Financial Results
* PATH HOLDINGS REPORTS FULL YEAR 2017 FINANCIAL RESULTS Source text for Eikon: Further company coverage: